Efficacy of Group Attachment Based Intervention for Vulnerable Families

Sponsor
Albert Einstein College of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT01641744
Collaborator
The New School (Other), Health Resources and Services Administration (HRSA) (U.S. Fed)
146
1
2
63
2.3

Study Details

Study Description

Brief Summary

The study examines the effectiveness of parent-child Group Attachment Based Intervention (GABI) in reducing risk of maltreatment in infants and toddlers compared with parenting skills classes. GABI directly addresses the needs of isolated, marginalized families, with the goals of of enhancing parent coping and resilience, and improving parent-child attachment relationships.

We hypothesize that compared to usual care, GABI will be associated with improved child, parent and parent-child outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Systematic Training for Effective Parenting (STEP)
  • Behavioral: Group Attachment Based Intervention (GABI)
N/A

Detailed Description

Child abuse and neglect ("maltreatment") pose enormous short- and long-term risks to children. Yet despite the critical importance of the U.S. Department of Health and Human Services, Maternal and Child Health Bureau's goal "to reduce fatal and non-fatal child maltreatment," non-empirically supported parenting skills classes remain child welfare agencies' standard approach to meeting this goal.

The study examines the effectiveness of parent-child Group Attachment Based Intervention (GABI) in reducing risk of maltreatment in infants and toddlers compared with parenting skills classes. GABI directly addresses the needs of isolated, marginalized families, with the goals of of enhancing parent coping and resilience, and improving parent-child attachment relationships.

Seventy families with children aged 2-36 months who are referred for parenting help will be randomly assigned to either GABI or "treatment as usual" that consists of parents-only parenting skills classes. Treatment will be offered for up to 6 months. Both groups will be assessed at baseline, end of treatment and at 6 months follow up.

Study Design

Study Type:
Interventional
Actual Enrollment :
146 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Birth to Three: A Pragmatic Clinical Trial for Child Maltreatment Prevention
Actual Study Start Date :
Aug 1, 2012
Actual Primary Completion Date :
Nov 1, 2017
Actual Study Completion Date :
Nov 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group Attachment Based Intervention (GABI)

Behavioral: Group Attachment Based Intervention (GABI)
Parent-child group, 3x/week, 26 weeks

Active Comparator: Systematic Training for Effective Parenting (STEP)

Behavioral: Systematic Training for Effective Parenting (STEP)
Parenting skills training class, 1x/week, 12 weeks

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in child exposure to trauma and maltreatment to end-of-treatment and at 6-month follow-up (Child Adverse Childhood Experiences Screener) [Measured at Baseline, End-of-Treatment (12 Weeks for Control/26 Weeks for Intervention), and at 6-Month Follow-up]

Secondary Outcome Measures

  1. Child cognitive development (Bayley III Screening Test) [Measured at Baseline, End-of-Treatment (12 Weeks for Control/26 Weeks for Intervention), and at 6-Month Follow-Up]

  2. Parent mental health (Symptoms Checklist-90) [Measured at Baseline, End-of-Treatment (12 Weeks for Control/26 Weeks for Intervention), and at 6-Month Follow-Up]

  3. Child social-emotional development (Ages and Stages Questionnaire) [Measured at Baseline, End-of-Treatment (12 Weeks for Control/26 Weeks for Intervention), and at 6-Month Follow-Up]

  4. Parent social support (Interpersonal Support Evaluation List) [Measured at Baseline, End-of-Treatment (12 Weeks for Control/26 Weeks for Intervention), and at 6-Month Follow-Up]

  5. Parenting stress (Parenting Stress Index) [Measured at Baseline, End-of-Treatment (12 Weeks for Control/26 Weeks for Intervention), and at 6-Month Follow-Up]

  6. Child-parent attachment (Strange Situation Procedure) and Free -Play Observation coded with Coding Interactive Behavior (CIB) dimensions [Measured at Baseline, End-of-Treatment (12 Weeks for Control/26 Weeks for Intervention, and at 6-Month Follow-Up]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 36 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Parents with children age 0-36 months

  • Parent(s) is/are biological parent of child (mother or father)

  • Parent(s) has/have custody of their child even if he/she/they have lost custody of previous children

  • Risk of maltreatment from referral source or intake interview, including parent's own childhood adversity, parent's current exposure to relationship violence, history of parental substance abuse or history of parental incarceration

  • If history of substance abuse, enrolled in treatment program

  • Willing to sign informed consent

Exclusion Criteria:
  • Parent is unable to provide informed consent due to cognitive impairment

  • Parent not fluent in English

  • Child has diagnosis of an autistic spectrum disorder or severe cognitive delay

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center for Babies, Toddlers and Families, division of The Early Childhood Center Bronx New York United States 10461

Sponsors and Collaborators

  • Albert Einstein College of Medicine
  • The New School
  • Health Resources and Services Administration (HRSA)

Investigators

  • Principal Investigator: Karen Bonuck, PhD, Albert Einstein College of Medicine
  • Principal Investigator: Anne Murphy, PhD, Albert Einstein College of Medicine
  • Study Director: Miriam Steele, PhD, The New School
  • Study Director: Howard Steele, PhD, The New School

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Karen Bonuck, Karen A. Bonuck, PhD (Professor), Albert Einstein College of Medicine
ClinicalTrials.gov Identifier:
NCT01641744
Other Study ID Numbers:
  • 2005-703
First Posted:
Jul 17, 2012
Last Update Posted:
Jun 28, 2018
Last Verified:
Jun 1, 2018
Keywords provided by Karen Bonuck, Karen A. Bonuck, PhD (Professor), Albert Einstein College of Medicine

Study Results

No Results Posted as of Jun 28, 2018